Depicting the Implication of miR-378a in Cancers

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA-378a (miR-378a), encoded by the PPARGC1B gene, is implicated in tumorigenesis.
• miR-378a functions as an independent prognostic biomarker across various malignant tumors.
• Aberrant miR-378a expression influences critical cellular processes like proliferation, apoptosis, invasion, metastasis, and therapeutic resistance.

Purpose of the Study:

• To comprehensively review the role and regulatory mechanisms of miR-378a in cancer development.
• To explore the dual functional role of miR-378a in promoting or inhibiting tumorigenesis.
• To provide insights into the potential therapeutic applications of miR-378a in cancer treatment.

Main Methods:

• Literature review of studies investigating miR-378a in cancer.
• Analysis of regulatory mechanisms controlling miR-378a expression and function.
• Synthesis of data on miR-378a's impact on cancer hallmarks.

Main Results:

• miR-378a exhibits a dual role in tumorigenesis, acting as both a promoter and inhibitor depending on the cancer type.
• miR-378a is involved in regulating cancer cell proliferation, apoptosis, invasion, and metastasis.
• The microRNA impacts therapeutic resistance in various cancer models.

Conclusions:

• miR-378a is a significant factor in cancer development and progression.
• Understanding miR-378a's complex regulatory network is crucial for its therapeutic exploitation.
• miR-378a holds promise as a potential therapeutic target for diverse cancers.